Woodcock to Lead Planned Pharmaceutical Quality Super Office

Drug Industry Daily
CDER Director Janet Woodcock has decided to head the FDA’s new Office of Pharmaceutical Quality (OPQ) herself until it gets off the ground. The new office is planned as a “super office” that will oversee manufacturing quality throughout a drug’s lifecycle.

To View This Article:


Subscribe To Drug Industry Daily